EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes

Nicola Frericks iD, Richard J P Brown, Birthe M Reinecke, Maike Herrmann, Yannick Brüggemann, Daniel Todt, Csaba Miskey, Florian W R Vondran, Eike Steinmann, Thomas Pietschmann iD, Julie Sheldon iD

Journal of Virology · 2024

DOI: 10.1128/jvi.01921-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Nicola Frericks und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Experimental Virology, TWINCORE, Hannover, Germany. Hauptthemen laut MEDLINE: Genetic Fitness, Hepacivirus, Hepatocytes, Host Microbial Interactions. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Deutsche Forschungsgemeinschaft, Deutsches Zentrum für Infektionsforschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) infection progresses to chronicity in the majority of infected individuals. Its high intra-host genetic variability enables HCV to evade the continuous selection pressure exerted by the host, contributing to persistent infection. Utilizing a cell culture-adapted HCV population (p100pop) which exhibits increased replicative capacity in various liver cell lines, this study investigated virus and host determinants that underlie enhanced viral fitness. Characterization of a panel of molecular p100 clones revealed that cell culture adaptive mutations optimize a range of virus-host interactions, resulting in expanded cell tropism, altered dependence on the cellular co-factor micro-RNA 122 and increased rates of virus spread. On the host side, comparative transcriptional profiling of hepatoma cells infected either with p100pop or its progenitor virus revealed that enhanced replicative fitness correlated with activation of endoplasmic reticulum stress signaling and the unfolded protein response. In contrast, infection of primary human hepatocytes with p100pop led to a mild attenuation of virion production which correlated with a greater induction of cell-intrinsic antiviral defense responses. In summary, long-term passage experiments in cells where selective pressure from innate immunity is lacking improves multiple virus-host interactions, enhancing HCV replicative fitness. However, this study further indicates that HCV has evolved to replicate at low levels in primary human hepatocytes to minimize innate immune activation, highlighting that an optimal balance between replicative fitness and innate immune induction is key to establish persistence. IMPORTANCE Hepatitis C virus (HCV) infection remains a global health burden with 58 million people currently chronically infected. However, the detailed molecular mechanisms that underly persistence are incompletely defined. We utilized a long-term cell culture-adapted HCV, exhibiting enhanced replicative fitness in different human liver cell lines, in order to identify molecular principles by which HCV optimizes its replication fitness. Our experimental data revealed that cell culture adaptive mutations confer changes in the host response and usage of various host factors. The latter allows functional flexibility at different stages of the viral replication cycle. However, increased replicative fitness resulted in an increased activation of the innate immune system, which likely poses boundary for functional variation in authentic hepatocytes, explaining the observed attenuation of the adapted virus population in primary hepatocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic FitnessHepacivirusHepatocytesHost Microbial InteractionsImmunity, InnateMutationHumansCells, CulturedEndoplasmic Reticulum StressHepatitis CMicroRNAsSerial PassageUnfolded Protein ResponseViral TropismVirionVirus Replication

Stichwörter der Autor:innen

hepatitis C virushost factorsinnate immunityvirus adaptation

Substanzen

MicroRNAsMIRN122 microRNA, human

Autor:innen und Institutionen

  • Institute for Experimental Virology, TWINCORE, Hannover, Germany.
  • Department for Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
  • Division of Veterinary Medicine, Paul Ehrlich Institute, Langen, Germany.
  • European Virus Bioinformatics Center (EVBC), Jena, Germany.
  • Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
  • Department for General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.

ORCID-Profile: Nicola Frericks, Thomas Pietschmann, Julie Sheldon

Förderung

  • NIAID NIH HHS
  • Deutsche Forschungsgemeinschaft
  • Deutsches Zentrum für Infektionsforschung
  • National Insitute for Allergy and Infectious Disease
  • Hannover Biomedical Research School
  • Center for Infection Biology
  • Bundesministerium für Gesundheit
  • Nationale Forschungsplatform für Zoonosen

Zitieren

APA

Frericks, N., Brown, R. J. P., Reinecke, B. M., Herrmann, M., Brüggemann, Y., Todt, D., Miskey, C., Vondran, F. W. R., Steinmann, E., Pietschmann, T., & Sheldon, J. (2024). Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes. Journal of Virology. https://doi.org/10.1128/jvi.01921-23

Vancouver

Frericks N, Brown RJP, Reinecke BM, Herrmann M, Brüggemann Y, Todt D, et al. Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes. Journal of Virology. 2024. doi:10.1128/jvi.01921-23

BibTeX
@article{Frericks2024,
  author = {Frericks, Nicola and Brown, Richard J P and Reinecke, Birthe M and Herrmann, Maike and Brüggemann, Yannick and Todt, Daniel and Miskey, Csaba and Vondran, Florian W R and Steinmann, Eike and Pietschmann, Thomas and Sheldon, Julie},
  title = {Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01921-23}
}
Kostenlos starten →